The Fibrolamellar Cancer Foundation (FCF) Research Grant Program 2026 supports research aimed at understanding, diagnosing, and treating fibrolamellar carcinoma (FLC), a rare form of liver cancer. The program welcomes projects ranging from preliminary studies to larger research programs and clinical studies.
Eligibility Criteria
- Applicants must be employed by an institution engaged in health-related research.
- Researchers from relevant academic and research institutions may apply.
- Projects must focus on fibrolamellar carcinoma.
- Collaboration and open sharing of data and research resources are required.
Funding Details
- Preliminary/Proof-of-Concept Studies: Up to $49,500 for 1 year
- Full Research Studies: Up to $200,000 per year for up to 2 years
- Clinical Studies: Funding and duration determined based on the proposed study
Deadline
- Application deadline: November 1, 2026
Further Information
- Applications are reviewed three times annually.
- Official Program Page.